| |
|
|
|
Adma Biologics  
|
|
2.165 -0.035 (-0.02%) |
10-21 16:00 |
|
Open: |
2.21 |
Pre close: |
2.2 |
Target:
|
2.83
|
|
High: |
2.2499 |
Low: |
2.155 |
Resistance:
|
2.42
2.70
|
|
Volume: |
2,303,851 |
Market Cap: |
187M |
Support:
|
1.98
1.65
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.24
 |
MACD |
MACD(12,26):
|
-0.05 |
|
MA(20): |
2.32  |
Signal(12,26,9): |
-0.04 |
|
MA(100): |
2.73 |
Stochastic Oscillator |
%K(14,3):
|
11.72 |
|
MA(250): |
3.23 |
%D(3): |
21.63 |
|
Average Volume(K) |
3-Month: |
666686
|
52-Week |
High:
|
5.25 |
|
10-Days: |
227062 |
Low: |
1.45 |
|
RSI |
RSI(14):
|
39.87 |
Change(%): |
-53.7 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.881 |
Return on Equity (ttm) |
-99.2 |
Shares Out. (M) |
86.35 |
|
EPS Est. Current Year |
-1.740 |
Return on Assets (ttm) |
-19.0 |
Shares Float (M) |
67.87 |
|
EPS Est. Next Year |
-1.080 |
PEG Ratio |
0.00 |
% Held by Insiders |
7.35 |
|
EPS Est. Next Quarter |
-0.370 |
Qtrly Rev. Growth |
18.7 |
% Held by Institutions |
47.91 |
|
Forward EPS |
-0.890 |
Gross Profit (p.s.) |
-0.118 |
Shares Short (K) |
13360 |
|
Book Value (p.s.) |
0.890 |
EBITDA (p.s.) |
-0.550 |
P/E |
-2.46 |
|
Sales Per Share |
0.431 |
Qtrly Earnings Growth |
0.00 |
P/BV |
2.43 |
|
Profit Margin |
-164.91 |
Operating Cash Flow
(M) |
-89.21 |
P/S |
5.02 |
|
Operating Margin |
-136.31 |
Levered Free Cash Flow
(M) |
-74.98 |
P/CF |
-2.10 |
|
|
|
|
|
|
